PDLIM7 and nasopharyngeal carcinoma: Multiple groups have shown that ebv-miR-BART1-5p, -BART16, and -BART17 can suppress an EBV latent membrane protein, LMP1, in infected B cells and NPC, which inhibits the LMP1-mediated activation of co-stimulatory molecules and antigen presentation [49,50,51].